Exact Mass: 630.4565

Exact Mass Matches: 630.4565

Found 144 metabolites which its exact mass value is equals to given mass value 630.4565, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Caldariellaquinone

Caldariellaquinone

C39H66O2S2 (630.4504)

A 1-benzothiophene that is 1-benzothiophene-4,7-dione bearing additional methylthio and 3,7,11,15,19,23-hexamethyltetracosyl substituents at positions 5 and 6 respectively. Isolated from Caldariella acidophila.

trans-1,4-Bis[[1-cyclohexyl-3-(4-dimethylamino phenyl)ureido]methyl]cyclohexane

3-cyclohexyl-3-({4-[(1-cyclohexyl{[4-(dimethylamino)phenyl]carbamoyl}amino)methyl]cyclohexyl}methyl)-1-[4-(dimethylamino)phenyl]urea

C38H58N6O2 (630.4621)

DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5Z,7R,8E,10Z,13Z,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0)

(2S)-3-hydroxy-2-(tridecanoyloxy)propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (4Z,7Z,10R,11E,13Z,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/13:0)

(2S)-2-hydroxy-3-(tridecanoyloxy)propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

(2S)-1-hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,7R,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C38H62O7 (630.4495)

DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,7S,8E,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,7S,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(a-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,7S,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2S)-1-hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (4Z,7Z,10R,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C38H62O7 (630.4495)

DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(a-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

(2S)-1-hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,7R,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoate

C38H62O7 (630.4495)

DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,7S,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(i-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,7S,10Z,13Z,15E,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (4Z,7Z,10R,11E,13Z,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(i-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10S,11E,13Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

C38H62O7

C38H62O7 (630.4495)

beta-amyrin-3-O-2-O-acetyl-beta-D-glucoside

beta-amyrin-3-O-2-O-acetyl-beta-D-glucoside

C38H62O7 (630.4495)

cyclomargenyl-3-O-beta-feruloyl ester

cyclomargenyl-3-O-beta-feruloyl ester

C42H62O4 (630.4648)

8beta-(4-steraoyloxyisoraleroyloxy)9beta-hydroxycostunolide|8beta-<4-steraoyloxyisoraleroyloxy>9beta-hydroxycostunolide

8beta-(4-steraoyloxyisoraleroyloxy)9beta-hydroxycostunolide|8beta-<4-steraoyloxyisoraleroyloxy>9beta-hydroxycostunolide

C38H62O7 (630.4495)

PA(P-16:0/16:1(9Z))

1-(1Z-hexadecenyl)-2-(9Z-hexadecenoyl)-glycero-3-phosphate

C35H67O7P (630.4624)

PA(P-18:0/14:1(9Z))

1-(1Z-octadecenyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C35H67O7P (630.4624)

PA O-32:2

1-(1Z-octadecenyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C35H67O7P (630.4624)

Zinc stearate

Zinc octadecanoate

C36H70O4Zn (630.4565)

Nutrient supplement

Magnesium stearate

Magnesium octadecanoate

C36H70O4Zn (630.4565)

It is used in foods as a binder, emulsifier, anticaking agent, lubricant and release agent, nutrient supplement, defoaming agent and processing aid.

1-Cyclohexyl-1-[[4-[[cyclohexyl-[[4-(dimethylamino)phenyl]carbamoyl]amino]methyl]cyclohexyl]methyl]-3-[4-(dimethylamino)phenyl]urea

1-Cyclohexyl-1-[[4-[[cyclohexyl-[[4-(dimethylamino)phenyl]carbamoyl]amino]methyl]cyclohexyl]methyl]-3-[4-(dimethylamino)phenyl]urea

C38H58N6O2 (630.4621)

3,4-Dihydroxy-5-all-trans-heptaprenylbenzoic acid

3,4-Dihydroxy-5-all-trans-heptaprenylbenzoic acid

C42H62O4 (630.4648)

DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0)

C38H62O7 (630.4495)

DG(13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

DG(13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/13:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/13:0)

C38H62O7 (630.4495)

DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0)

C38H62O7 (630.4495)

DG(13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

DG(13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/13:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/13:0)

C38H62O7 (630.4495)

DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0)

C38H62O7 (630.4495)

DG(a-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

DG(a-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/a-13:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/a-13:0)

C38H62O7 (630.4495)

DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0)

C38H62O7 (630.4495)

DG(a-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

DG(a-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/a-13:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/a-13:0)

C38H62O7 (630.4495)

DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0)

C38H62O7 (630.4495)

DG(i-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

DG(i-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-13:0)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-13:0)

C38H62O7 (630.4495)

DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0)

C38H62O7 (630.4495)

DG(i-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

DG(i-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-13:0)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-13:0)

C38H62O7 (630.4495)

Fahfa 22:6/20:4

Fahfa 22:6/20:4

C42H62O4 (630.4648)

Fahfa 20:5/22:5

Fahfa 20:5/22:5

C42H62O4 (630.4648)

2-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[2-hexanoyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-hexanoyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[2-butanoyloxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-butanoyloxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[hydroxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[3-decoxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-decoxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[2-decanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-decanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[2-acetyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-acetyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

BisMePA(30:2)

BisMePA(16:2(1)_14:0)

C35H67O7P (630.4624)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

OAHFA(42:10)

OAHFA(20:4_22:6)

C42H62O4 (630.4648)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 16:3/O-26:7

FAHFA 16:3/O-26:7

C42H62O4 (630.4648)

FAHFA 16:4/O-26:6

FAHFA 16:4/O-26:6

C42H62O4 (630.4648)

FAHFA 16:5/O-26:5

FAHFA 16:5/O-26:5

C42H62O4 (630.4648)

FAHFA 17:3/O-25:7

FAHFA 17:3/O-25:7

C42H62O4 (630.4648)

FAHFA 17:4/O-25:6

FAHFA 17:4/O-25:6

C42H62O4 (630.4648)

FAHFA 17:5/O-25:5

FAHFA 17:5/O-25:5

C42H62O4 (630.4648)

FAHFA 18:3/O-24:7

FAHFA 18:3/O-24:7

C42H62O4 (630.4648)

FAHFA 18:4/O-24:6

FAHFA 18:4/O-24:6

C42H62O4 (630.4648)

FAHFA 18:5/O-24:5

FAHFA 18:5/O-24:5

C42H62O4 (630.4648)

FAHFA 18:6/O-24:4

FAHFA 18:6/O-24:4

C42H62O4 (630.4648)

FAHFA 19:3/O-23:7

FAHFA 19:3/O-23:7

C42H62O4 (630.4648)

FAHFA 19:4/O-23:6

FAHFA 19:4/O-23:6

C42H62O4 (630.4648)

FAHFA 19:5/O-23:5

FAHFA 19:5/O-23:5

C42H62O4 (630.4648)

FAHFA 19:6/O-23:4

FAHFA 19:6/O-23:4

C42H62O4 (630.4648)

FAHFA 20:3/O-22:7

FAHFA 20:3/O-22:7

C42H62O4 (630.4648)

FAHFA 20:4/O-22:6

FAHFA 20:4/O-22:6

C42H62O4 (630.4648)

FAHFA 20:5/O-22:5

FAHFA 20:5/O-22:5

C42H62O4 (630.4648)

FAHFA 20:6/O-22:4

FAHFA 20:6/O-22:4

C42H62O4 (630.4648)

FAHFA 21:3/O-21:7

FAHFA 21:3/O-21:7

C42H62O4 (630.4648)

FAHFA 21:4/O-21:6

FAHFA 21:4/O-21:6

C42H62O4 (630.4648)

FAHFA 21:5/O-21:5

FAHFA 21:5/O-21:5

C42H62O4 (630.4648)

FAHFA 21:6/O-21:4

FAHFA 21:6/O-21:4

C42H62O4 (630.4648)

FAHFA 21:7/O-21:3

FAHFA 21:7/O-21:3

C42H62O4 (630.4648)

FAHFA 22:4/O-20:6

FAHFA 22:4/O-20:6

C42H62O4 (630.4648)

FAHFA 22:5/O-20:5

FAHFA 22:5/O-20:5

C42H62O4 (630.4648)

FAHFA 22:6/O-20:4

FAHFA 22:6/O-20:4

C42H62O4 (630.4648)

FAHFA 22:7/O-20:3

FAHFA 22:7/O-20:3

C42H62O4 (630.4648)

FAHFA 23:4/O-19:6

FAHFA 23:4/O-19:6

C42H62O4 (630.4648)

FAHFA 23:5/O-19:5

FAHFA 23:5/O-19:5

C42H62O4 (630.4648)

FAHFA 23:6/O-19:4

FAHFA 23:6/O-19:4

C42H62O4 (630.4648)

FAHFA 23:7/O-19:3

FAHFA 23:7/O-19:3

C42H62O4 (630.4648)

FAHFA 24:4/O-18:6

FAHFA 24:4/O-18:6

C42H62O4 (630.4648)

FAHFA 24:5/O-18:5

FAHFA 24:5/O-18:5

C42H62O4 (630.4648)

FAHFA 24:6/O-18:4

FAHFA 24:6/O-18:4

C42H62O4 (630.4648)

FAHFA 24:7/O-18:3

FAHFA 24:7/O-18:3

C42H62O4 (630.4648)

FAHFA 25:5/O-17:5

FAHFA 25:5/O-17:5

C42H62O4 (630.4648)

FAHFA 25:6/O-17:4

FAHFA 25:6/O-17:4

C42H62O4 (630.4648)

FAHFA 25:7/O-17:3

FAHFA 25:7/O-17:3

C42H62O4 (630.4648)

FAHFA 26:5/O-16:5

FAHFA 26:5/O-16:5

C42H62O4 (630.4648)

FAHFA 26:6/O-16:4

FAHFA 26:6/O-16:4

C42H62O4 (630.4648)

FAHFA 26:7/O-16:3

FAHFA 26:7/O-16:3

C42H62O4 (630.4648)

FAHFA 42:10;O

FAHFA 42:10;O

C42H62O4 (630.4648)

PA O-14:0/18:2

PA O-14:0/18:2

C35H67O7P (630.4624)

PA O-14:1/18:1

PA O-14:1/18:1

C35H67O7P (630.4624)

PA O-16:1/16:1

PA O-16:1/16:1

C35H67O7P (630.4624)

PA O-16:2/16:0

PA O-16:2/16:0

C35H67O7P (630.4624)

PA O-18:1/14:1

PA O-18:1/14:1

C35H67O7P (630.4624)

PA O-18:2/14:0

PA O-18:2/14:0

C35H67O7P (630.4624)

PA O-20:2/12:0

PA O-20:2/12:0

C35H67O7P (630.4624)

PA O-22:2/10:0

PA O-22:2/10:0

C35H67O7P (630.4624)

PA P-14:0/18:1

PA P-14:0/18:1

C35H67O7P (630.4624)

PA P-14:0/18:1 or PA O-14:1/18:1

PA P-14:0/18:1 or PA O-14:1/18:1

C35H67O7P (630.4624)

PA P-16:0/16:1

PA P-16:0/16:1

C35H67O7P (630.4624)

PA P-16:0/16:1 or PA O-16:1/16:1

PA P-16:0/16:1 or PA O-16:1/16:1

C35H67O7P (630.4624)

PA P-16:1/16:0

PA P-16:1/16:0

C35H67O7P (630.4624)

PA P-16:1/16:0 or PA O-16:2/16:0

PA P-16:1/16:0 or PA O-16:2/16:0

C35H67O7P (630.4624)

PA P-18:0/14:1

PA P-18:0/14:1

C35H67O7P (630.4624)

PA P-18:0/14:1 or PA O-18:1/14:1

PA P-18:0/14:1 or PA O-18:1/14:1

C35H67O7P (630.4624)

PA P-18:1/14:0

PA P-18:1/14:0

C35H67O7P (630.4624)

PA P-18:1/14:0 or PA O-18:2/14:0

PA P-18:1/14:0 or PA O-18:2/14:0

C35H67O7P (630.4624)

PA P-20:1/12:0

PA P-20:1/12:0

C35H67O7P (630.4624)

PA P-20:1/12:0 or PA O-20:2/12:0

PA P-20:1/12:0 or PA O-20:2/12:0

C35H67O7P (630.4624)

PA P-22:1/10:0

PA P-22:1/10:0

C35H67O7P (630.4624)

PA P-22:1/10:0 or PA O-22:2/10:0

PA P-22:1/10:0 or PA O-22:2/10:0

C35H67O7P (630.4624)

PA P-32:1

PA P-32:1

C35H67O7P (630.4624)

PA P-32:1 or PA O-32:2

PA P-32:1 or PA O-32:2

C35H67O7P (630.4624)

LPEth 30:2

LPEth 30:2

C35H67O7P (630.4624)

LPM 31:2

LPM 31:2

C35H67O7P (630.4624)

(5-oxo-1,4-dioxacyclononacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(5-oxo-1,4-dioxacyclononacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H62O7 (630.4495)

[(2s)-5-oxo-1,4-dioxacyclononacosan-2-yl]methyl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(2s)-5-oxo-1,4-dioxacyclononacosan-2-yl]methyl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H62O7 (630.4495)

[(2s)-5-oxo-1,4-dioxacyclononacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(2s)-5-oxo-1,4-dioxacyclononacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H62O7 (630.4495)